Vaccinating females against human papillomavirus (HPV) prior to the debut of sexual activity is an effective way to prevent cervical cancer, yet vaccine uptake in low- and middle-income countries ...

The Cancer Prevention and Research Institute of Texas has awarded nearly $3.4 million to UT Health San Antonio to advance ...

Very low-certainty evidence means that we were uncertain about the result. Conclusion A two-dose schedule of HPV vaccines in young females results in immune system responses that are comparable with a ...

Kennedy’s decision to replace ACIP wholesale and the comments he has made about deviating from standard vaccine policymaking ...

The Cancer Prevention and Research Institute of Texas awarded the university more than $2.4 million to tailor treatments for ...

The Serum Institute of India has launched a nationwide campaign to raise awareness about HPV's role in causing various ...

Basically all epidemiological studies report the presence of HPV-16 in about half of the tumors followed by HPV-18 in approximately 18% of the samples. [11, 12] This pattern closely resembles the ...

277 young women (mean age 20·2 years [SD 1·7]) were randomly assigned to quadrivalent HPV (20 μg type 6, 40 μg type 11, 40 μg type 16, and 20 μg type 18) L1 virus-like-particle (VLP) vaccine and 275 ...

In a deposition last year, Kulldorff estimated that he earned $49,000 as a $400-an-hour expert for plaintiffs who claimed Merck’s Gardasil vaccine, which protects against HPV, caused injuries.

Human papillomaviruses (HPV) are DNA viruses with a double strand of DNA that belong to the family Papovaviridae. 1 Currently, nearly 200 HPV types have been identified and are categorised into two ...

The urgent need for effective vaccines has prompted vaccine developers to pivot towards COVID-19, resulting in rapid growth of preclinical candidates (appendix) and an accelerated vaccine development ...

News GlobeNewswire IMUNON Announces PlaCCine® DNA Vaccine Technology Abstract Selected for Oral Presentation at 10th International Conference on Vaccines Research & Development™ ...